Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-7.32%
+0.14%
-1.99%
-3.06%
MBOT
Microbot Medical Inc.
$3.17
Login to see Microbot Medical Inc. (MBOT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Upgraded on attractively valued
Earnings are forecast to grow
Chart
$4.5 (-29.56%)
$2.62 (+20.99%)
$2.38 (+33.19%)
$0.97 (+226.80%)
MBOT has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
High volatilty
MBOT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
MBOT Analysts opinion is positive and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MBOT Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayMBOT Earnings
The TTM reflects 12-month period, providing review of MBOT financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is MBOT current stock price?
What are MBOT stock strengths?
What risks are associated with MBOT stock?
When is MBOT next earnings report?
What is MBOT market cap and volume?
What is MBOT's current Stock IQ?
Should I buy MBOT stock right now?
Is MBOT a Strong Buy right now?
What does a 'Strong Buy' rating mean for MBOT?
What does a 'Strong Sell' rating mean for MBOT?
What factors influence MBOT's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.32%
+0.14%
-1.99%
-3.06%
MBOT
Microbot Medical Inc.
Current Price
$3.17
Stock Insights
Strengths
Upgraded on attractively valued
Earnings are forecast to grow
Login to unlock Microbot Medical Inc. (MBOT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$4.5 (-29.56%)
$2.62 (+20.99%)
$2.38 (+33.19%)
$0.97 (+226.80%)
MBOT Analysts Opinion
MBOT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
MBOT Analysts opinion is positive and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MBOT Street view is extremely bullish and have positive views on the near-term outlook
MBOT has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Price under $5
High volatilty
Average key support and resistance price levels.
Login to displayMBOT Earnings
The TTM data reflects the most recent 12-month period, providing overview of MBOT financial performance.
MBOT Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
MBOT Latest Analysis
All You Need to Know About Microbot Medical (MBOT) Rating Upgrade to Buy. Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Fri Sep 26, 2025
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds. HINGHAM Mass. Sept. 16 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ:) (Microbot or the Company) today announced the first closing of its previously announced exercise of certain outstanding preferred investment options to purchase up to an aggregate of 13989115 shares of common stock. The shares of common stock issuable upon exercise of the preferre
Tue Sep 16, 2025
Microbot Medical raises $25.2 million through investment options.
Tue Sep 16, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MBOT Stock trends
MBOT Stock performance
MBOT Stock analysis
MBOT investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings